Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2020 May 15;26(8):1402–1405. doi: 10.1016/j.bbmt.2020.04.024

Figure 2.

Figure 2.

A) OS in patients with BMPC ≥10% based on the B2M level. B) OS in patients with BMPC <10% based on B2M level. OS: Overall survival, B2M: beta-2 microglobulin. BMPC: bone marrow plasma cell.